Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange
Abstract Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis causes end-stage renal failure in up to a third of cases even with treatment. The disease recurs occasionally after kidney transplantation, but new onset of ANCA-associated vasculitis after transplantation is highl...
Main Authors: | Michael S. Sagmeister, Max Weiss, Peter Eichhorn, Antje Habicht, Rupert Habersetzer, Michael Fischereder, Ulf Schönermarck |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-1086-z |
Similar Items
-
Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
by: Nankee K. Kumar, AB, et al.
Published: (2024-03-01) -
Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01) -
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01) -
Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01) -
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
by: Mark E. McClure, et al.
Published: (2023-03-01)